Integrated treatment to achieve functional recovery for first-episode psychosis
- PMID: 22970366
- PMCID: PMC3420493
- DOI: 10.1155/2012/962371
Integrated treatment to achieve functional recovery for first-episode psychosis
Abstract
This study describes an integrated treatment approach that was implemented to enhance functional recovery in first-episode psychotic patients. Patients were randomized to two treatment conditions: either to an integrated treatment approach: pharmacotherapy, psychosocial treatment, and psychoeducation (experimental group: N = 39) or to medication alone (control group: N = 34). Patients were evaluated at baseline and after one year of treatment. Functional recovery was assessed according to symptomatic and functional remission. At the end of treatment, experimental patients showed a 94.9% of symptomatic remission compared to 58.8% of the control group. Functional remission was 56.4% for the experimental group and 3.6% for the control group, while 56.4% of the experimental group met both symptomatic and functional remission criteria and were considered recovered compared to 2.9% of the control group.
References
-
- Burns T, Patrick D. Social functioning as an outcome measure in schizophrenia studies. Acta Psychiatrica Scandinavica. 2007;116(6):403–418. - PubMed
-
- Melle I, Haahr U, Friis S, et al. Reducing the duration of untreated first-episode psychosis—effects on baseline social functioning and quality of life. Acta Psychiatrica Scandinavica. 2005;112(6):469–473. - PubMed
-
- Rocca P, Castagna F, Mongini T, Montemagni C, Bogetto F. Relative contributions of psychotic symptoms and insight to quality of life in stable schizophrenia. Psychiatry Research. 2010;177(1-2):71–76. - PubMed
-
- World Health Organization. World Health Report. Mental health: new understanding, new hope. WHO, Geneva, Switzerland, 2001.
LinkOut - more resources
Full Text Sources
Miscellaneous
